1. Home
  2. KYTX vs PERF Comparison

KYTX vs PERF Comparison

Compare KYTX & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • PERF
  • Stock Information
  • Founded
  • KYTX 2018
  • PERF 2015
  • Country
  • KYTX United States
  • PERF Taiwan
  • Employees
  • KYTX N/A
  • PERF N/A
  • Industry
  • KYTX
  • PERF Computer Software: Prepackaged Software
  • Sector
  • KYTX
  • PERF Technology
  • Exchange
  • KYTX NYSE
  • PERF Nasdaq
  • Market Cap
  • KYTX 242.1M
  • PERF 197.6M
  • IPO Year
  • KYTX 2024
  • PERF N/A
  • Fundamental
  • Price
  • KYTX $3.99
  • PERF $1.88
  • Analyst Decision
  • KYTX Buy
  • PERF Buy
  • Analyst Count
  • KYTX 5
  • PERF 2
  • Target Price
  • KYTX $23.20
  • PERF $4.00
  • AVG Volume (30 Days)
  • KYTX 248.8K
  • PERF 59.0K
  • Earning Date
  • KYTX 11-13-2024
  • PERF 10-29-2024
  • Dividend Yield
  • KYTX N/A
  • PERF N/A
  • EPS Growth
  • KYTX N/A
  • PERF N/A
  • EPS
  • KYTX N/A
  • PERF 0.05
  • Revenue
  • KYTX N/A
  • PERF $58,445,000.00
  • Revenue This Year
  • KYTX N/A
  • PERF $15.77
  • Revenue Next Year
  • KYTX N/A
  • PERF $13.89
  • P/E Ratio
  • KYTX N/A
  • PERF $37.04
  • Revenue Growth
  • KYTX N/A
  • PERF 15.84
  • 52 Week Low
  • KYTX $3.94
  • PERF $1.70
  • 52 Week High
  • KYTX $30.60
  • PERF $3.77
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 30.54
  • PERF 49.60
  • Support Level
  • KYTX $3.94
  • PERF $1.78
  • Resistance Level
  • KYTX $4.34
  • PERF $1.92
  • Average True Range (ATR)
  • KYTX 0.38
  • PERF 0.08
  • MACD
  • KYTX -0.10
  • PERF 0.00
  • Stochastic Oscillator
  • KYTX 2.99
  • PERF 57.14

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About PERF Perfect Corp.

Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions that are ultra-personalized, interactive and engaging, from online to in-store through beauty mirrors. Geographically, the company has a presence in the United States, France, Japan and Others.

Share on Social Networks: